Thema: JP3475350009
Daiichi Sankyo, JP3475350009
money-5338733_1280.jpg - Foto: THN
Nomura keeps JPY 3,800.00 target for Daiichi Sankyo stock
Results are due October 30, 2026. Daiichi Sankyo stock costs JPY 2,740.50 on October 16, 2026, up 3.38 percent versus Tokyo's October 15 close.
ad-hoc-news.de, heute 21:16 Uhr
Daiichi Sankyo, JP3475350009
Nomura keeps JPY 3 800.00 target for Daiichi Sankyo stock ...
Daiichi Sankyo reports on October 30, 2026. Daiichi Sankyo stock costs EUR 14.98 on October 15, 2026 at 10:45 p.m. CEST.
ad-hoc-news.de, 15.10.26 22:46 Uhr
Daiichi Sankyo, JP3475350009
Daiichi Sankyo stock gets Citi Buy rating with JPY 4 700 ...
On October 7, 2026, Citi kept a Buy view on Daiichi Sankyo. June-quarter revenue reached JPY 574.74 billion, up from JPY 474.6 billion.
ad-hoc-news.de, 08.10.26 04:25 Uhr
Daiichi Sankyo, JP3475350009
Daiichi Sankyo stock faces setback after I-DXd filing withdrawal ...
Daiichi Sankyo stock was last at JPY 2,752 on October 6, 2026, after an I-DXd filing withdrawal. First-quarter revenue rose 21.1 percent.
ad-hoc-news.de, 07.10.26 01:36 Uhr
Daiichi Sankyo, JP3475350009
Daiichi Sankyo expands Datroway trials: what it means for ...
For Daiichi Sankyo stock, the plan means seven DXd ADC programs. First-quarter revenue rose 21.10 percent to JPY 574.7 billion.
ad-hoc-news.de, 05.10.26 03:44 Uhr
Daiichi Sankyo, JP3475350009
Daiichi Sankyo stock edges higher after EU clears Enhertu ...
Daiichi Sankyo stock benefits from fresh EU approval for the Enhertu plus pertuzumab regimen in HER2-positive breast cancer as Tokyo-listed shares trade in the mid-„2 800 ...
ad-hoc-news.de, 01.09.26 11:07 Uhr
Daiichi Sankyo, JP3475350009
Daiichi Sankyo stock holds steady as new oncology trial ...
Daiichi Sankyo stock is trading within its recent range while investors weigh solid quarterly revenue growth against a modest earnings miss and a newly opened first-in-human ...
ad-hoc-news.de, 31.08.26 21:55 Uhr
Daiichi Sankyo, JP3475350009
Daiichi Sankyo Stock - New „200 billion loan underpins ...
Daiichi Sankyo has secured a „200 billion syndicated loan strengthening its balance sheet as it invests in oncology pipelines. The move comes after a volatile week for the ...
ad-hoc-news.de, 19.06.26 22:03 Uhr
Daiichi Sankyo, JP3475350009
Daiichi Sankyo Co Ltd Stock (JP3475350009): Pharma name ...
Daiichi Sankyo shares are in focus as partner Merck has issued a 2026 update on the manufacturing and supply plan for their jointly developed ADC portfolio while the Tokyo-listed ...
ad-hoc-news.de, 12.06.26 14:48 Uhr
Daiichi Sankyo, JP3475350009
Daiichi Sankyo Co Ltd stock (JP3475350009): oncology momentum ...
